Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Dyne Therapeutics, Inc. (DYN)  
$31.88 0.68 (2.18%) as of 4:30 Fri 5/31


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 81,110,000
Market Cap: 2.59(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $6.62 - $35.38
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 21.5
Insider 3/6 Months : 22.1
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Dyne Therapeutics is a muscle disease company focused on developing therapeutics for people living with genetically driven diseases. Co. is developing the following product candidates: DYNE-101, to address the genetic basis of myotonic dystrophy type 1 by targeting the toxic nuclear DMPK RNA that causes the disease; DYNE-251 for patients with mutations amenable to skipping Exon 51, to be followed by the development of therapeutics for patients with mutations amenable to skipping other exons, including Exon 53, 45 and 44; and DYNE-301 to address the genetic basis of facioscapulohumeral dystrophy by reducing DUX4 expression in muscle tissue.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 1,714,285 1,714,285 3,583,447
Total Buy Value $0 $29,999,988 $29,999,988 $50,000,022
Total People Bought 0 1 1 3
Total Buy Transactions 0 1 1 3
Total Shares Sold 733,732 5,067,912 5,495,480 5,751,795
Total Sell Value $19,312,085 $120,465,489 $125,810,009 $128,995,680
Total People Sold 6 9 9 9
Total Sell Transactions 23 77 99 109
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 229
  Page 4 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Scalzo Richard William SVP, Head of Finance & Admin.   •       –      –    2024-01-26 4 OE $1.03 $13,390 D/D 13,000 137,228     -
   Kersten Dirk   –       •       •   2024-01-09 4 B $17.50 $29,999,988 I/I 1,714,285 1,428,571 0.01 88%     
   Beskrovnaya Oxana Chief Scientific Officer   •       –      –    2024-01-04 4 AS $18.13 $769,673 D/D (42,453) 156,806 52%     
   Beskrovnaya Oxana Chief Scientific Officer   •       –      –    2024-01-04 4 OE $1.03 $23,354 D/D 22,674 199,259     -
   Mcneill Jonathan Chief Business Officer   •       –      –    2024-01-04 4 AS $18.04 $36,242 D/D (2,009) 143,618 52%     
   Mcneill Jonathan Chief Business Officer   •       –      –    2024-01-04 4 OE $0.73 $1,467 D/D 2,009 145,627     -
   Brumm Joshua T CEO & President   •       –      –    2024-01-04 4 AS $18.40 $4,045,958 D/D (218,536) 584,971 52%     
   Brumm Joshua T CEO & President   •       –      –    2024-01-04 4 OE $1.03 $1,127,092 D/D 218,536 803,507     -
   Beskrovnaya Oxana Chief Scientific Officer   •       –      –    2024-01-03 4 AS $18.34 $860,313 D/D (45,326) 176,585 91%     
   Beskrovnaya Oxana Chief Scientific Officer   •       –      –    2024-01-03 4 OE $1.03 $46,686 D/D 45,326 221,911     -
   Mcneill Jonathan Chief Business Officer   •       –      –    2024-01-03 4 AS $18.34 $337,062 D/D (17,991) 143,618 91%     
   Mcneill Jonathan Chief Business Officer   •       –      –    2024-01-03 4 OE $0.73 $13,133 D/D 17,991 161,609     -
   Scalzo Richard William SVP, Head of Finance & Admin.   •       –      –    2024-01-03 4 AS $18.81 $244,530 D/D (13,000) 124,228 91%     
   Scalzo Richard William SVP, Head of Finance & Admin.   •       –      –    2024-01-03 4 OE $1.03 $13,390 D/D 13,000 137,228     -
   Brumm Joshua T CEO & President   •       –      –    2024-01-03 4 AS $18.34 $986,957 D/D (51,183) 584,971 91%     
   Brumm Joshua T CEO & President   •       –      –    2024-01-03 4 OE $1.03 $52,718 D/D 51,183 636,154     -
   Mcneill Jonathan Chief Business Officer   •       –      –    2024-01-02 4 AS $13.10 $155,890 D/D (11,900) 143,618 104%     
   Scalzo Richard William See Remarks   •       –      –    2023-12-14 4 AS $12.02 $28,560 D/D (2,376) 124,228 109%     
   Farwell Wildon Chief Medical Officer   •       –      –    2023-12-12 4 AS $10.55 $10,318 D/D (978) 169,096 128%     
   Brumm Joshua T See Remarks   •       •      –    2023-12-11 4 AS $10.72 $81,311 D/D (7,585) 584,971 133%     
   Mcneill Jonathan Chief Business Officer   •       –      –    2023-12-11 4 AS $10.72 $13,346 D/D (1,245) 155,518 133%     
   Farwell Wildon Chief Medical Officer   •       –      –    2023-12-11 4 AS $10.72 $18,095 D/D (1,688) 170,074 133%     
   Scalzo Richard William See Remarks   •       –      –    2023-12-11 4 AS $10.72 $14,794 D/D (1,380) 126,604 133%     
   High Susanna Gatti Chief Operating Officer   •       –      –    2023-12-11 4 AS $10.72 $17,324 D/D (1,616) 187,882 133%     
   Beskrovnaya Oxana Chief Scientific Officer   •       –      –    2023-12-11 4 AS $10.72 $15,726 D/D (1,467) 176,585 133%     
  229 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 4 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us